Free Trial

EUDA Health (EUDA) Competitors

$3.58
-0.29 (-7.49%)
(As of 07/26/2024 ET)

EUDA vs. PCX, NOVV, PAFO, PPHP, DILA, LFMD, VMD, AIRS, SERA, and BDSX

Should you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include Parsec Capital Acquisitions (PCX), Nova Vision Acquisition (NOVV), Pacifico Acquisition (PAFO), PHP Ventures Acquisition (PPHP), DILA Capital Acquisition (DILA), LifeMD (LFMD), Viemed Healthcare (VMD), AirSculpt Technologies (AIRS), Sera Prognostics (SERA), and Biodesix (BDSX).

EUDA Health vs.

Parsec Capital Acquisitions (NASDAQ:PCX) and EUDA Health (NASDAQ:EUDA) are both small-cap unclassified companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking.

72.5% of Parsec Capital Acquisitions shares are held by institutional investors. Comparatively, 4.4% of EUDA Health shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, EUDA Health had 2 more articles in the media than Parsec Capital Acquisitions. MarketBeat recorded 2 mentions for EUDA Health and 0 mentions for Parsec Capital Acquisitions. Parsec Capital Acquisitions' average media sentiment score of 1.44 beat EUDA Health's score of 0.00 indicating that EUDA Health is being referred to more favorably in the news media.

Company Overall Sentiment
Parsec Capital Acquisitions Neutral
EUDA Health Positive

Parsec Capital Acquisitions and EUDA Health both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Parsec Capital AcquisitionsN/AN/A
EUDA HealthN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Parsec Capital Acquisitions
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Parsec Capital Acquisitions has higher earnings, but lower revenue than EUDA Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Parsec Capital AcquisitionsN/AN/AN/AN/AN/A
EUDA Health$3.71M23.77-$10.04MN/AN/A

Company Net Margins Return on Equity Return on Assets
Parsec Capital AcquisitionsN/A N/A N/A
EUDA Health N/A N/A N/A

Summary

EUDA Health beats Parsec Capital Acquisitions on 3 of the 4 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EUDA vs. The Competition

MetricEUDA HealthHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$88.18M$934.78M$5.32B$8.20B
Dividend YieldN/A1.83%2.72%3.97%
P/E RatioN/A41.01157.2518.66
Price / Sales23.773.312,080.7091.73
Price / CashN/A21.2935.7934.11
Price / Book-11.932.454.954.51
Net Income-$10.04M-$13.76M$112.23M$216.36M
7 Day Performance-10.50%0.14%2.72%1.82%
1 Month Performance-14.15%4.58%6.96%7.09%
1 Year Performance550.79%66.88%11.22%4.89%

EUDA Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PCX
Parsec Capital Acquisitions
0 of 5 stars
0.00 / 5 stars
$10.20
flat
N/A+0.0%$109.97MN/A0.002,021
NOVV
Nova Vision Acquisition
0 of 5 stars
0.00 / 5 stars
$12.08
flat
N/A+8.5%$40.08MN/A604.302,021Positive News
PAFO
Pacifico Acquisition
0 of 5 stars
0.00 / 5 stars
$4.20
flat
N/A+0.0%$31.48MN/A0.002,021Gap Up
PPHP
PHP Ventures Acquisition
0 of 5 stars
0.00 / 5 stars
$11.07
flat
N/AN/A$28.75MN/A-27.672,021
DILA
DILA Capital Acquisition
0 of 5 stars
0.00 / 5 stars
$10.04
flat
N/A+0.0%$22.73MN/A0.002,021
LFMD
LifeMD
1.5488 of 5 stars
1.55 / 5 stars
$7.03
+1.0%
$12.17
+73.1%
+80.7%$293.55M$163.56M-9.50230News Coverage
VMD
Viemed Healthcare
2.1199 of 5 stars
2.12 / 5 stars
$7.42
-2.0%
N/A-17.6%$288.05M$194.05M28.54630Positive News
AIRS
AirSculpt Technologies
2.6938 of 5 stars
2.69 / 5 stars
$4.75
+1.3%
$7.00
+47.4%
-44.1%$270.00M$197.72M237.50240News Coverage
SERA
Sera Prognostics
0.7026 of 5 stars
0.70 / 5 stars
$8.43
+5.0%
$2.75
-67.4%
+202.2%$262.21M$206,000.00-7.88120Short Interest ↑
News Coverage
BDSX
Biodesix
3.696 of 5 stars
3.70 / 5 stars
$1.72
+3.6%
$3.08
+78.8%
+60.7%$197.27M$49.09M-3.13220Analyst Forecast
Short Interest ↓
News Coverage
Positive News
Gap Up

Related Companies and Tools

This page (NASDAQ:EUDA) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners